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Abstract
The theoretical discovery of Sanal flow choking in the cardiovascular system 
(CVS) demands for interdisciplinary studies and universal actions to propose 
modern medications and to discover new drugs to annul the risk of flow-choking 
leading to shock-wave generation causing asymptomatic-cardiovascular-diseases. 
In this chapter we show that when blood-pressure-ratio (BPR) reaches the lower-
critical-hemorrhage-index (LCHI) the flow-choking could occur in the CVS with 
and without stent. The flow-choking is uniquely regulated by the biofluid/blood-
heat-capacity-ratio (BHCR). The BHCR is well correlated with BPR, blood-viscosity 
and ejection-fraction. The closed-form analytical models reveal that the relatively 
high and the low blood-viscosity are cardiovascular-risk factors. In vitro data shows 
that nitrogen, oxygen, and carbon dioxide gases are predominant in fresh blood 
samples of the human being/Guinea-pig at a temperature range of 37–40 °C (98.6–
104 °F). In silico results demonstrate the occurrence of Sanal flow choking leading 
to shock wave generation and pressure-overshoot in CVS without any apparent 
occlusion. We could conclude authoritatively, without any ex vivo or in vivo studies, 
that the Sanal flow choking in CVS leads to asymptomatic-cardiovascular-diseases. 
The cardiovascular-risk could be diminished by concurrently lessening the viscosity 
of biofluid/blood and flow-turbulence by increasing the thermal-tolerance level in 
terms of BHCR and/or by decreasing the BPR.
Keywords: asymptomatic cardiovascular disease, biofluid choking, BHCR,  
risk factors, sanal flow choking
1. Introduction
The cardiovascular system (blood circulatory system) is an internal fluid flow 
loop with multiple branches, transport nutrients and oxygen to all cells in the body. 
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The center of the cardiovascular system (CVS) is the heart, which is accountable 
to pump blood through the complex network of viscoelastic vessels, viz., arteries, 
veins and capillaries. Blood flow in CVS is inherently an unsteady phenomenon 
experiencing with transient events. Blood flow begins when the heart relaxes 
between two heartbeats. Due to the cyclic nature of the heart the velocity and 
pressure of the internal fluid (blood/biofluid) circulating through the viscoelastic 
vessels varies with time. Blood flow in CVS is typically laminar but due to its 
pulsatile nature makes possible the flow transition to turbulent. Furthermore, the 
variations in the fluid flow properties and vessel geometry due to pathophysiologi-
cal reasons, including the seasonal effects, contribute for the transition of laminar 
flow to turbulent.
Diseases of the CVS are manifold in gravity and microgravity environment 
(human spaceflight) and afflict millions of patients worldwide including cases of: 
coronary artery disease (CAD), ischemic gangrene, abdominal aortic aneurysms, 
moyamoya disease, and stroke. A few of these dysfunctions are reported to be the 
end result of atherosclerosis, characterized by plaque accumulation within the walls 
of the arteries. Atherosclerotic cardiovascular disease (CVD) is the leading cause 
of death for both men and women. There is no clear age cut point for defining the 
onset of risk for CVD, which is corroborated from the clinically detected elevated 
risk factor levels and subclinical abnormalities of adolescents as well as young 
adults. The hemodynamic characteristics of blood flow have long been thought 
to play an important role in the pathogenesis of atherosclerosis. In light of the 
discovery of internal flow choking in CVS [1, 2], the hemodynamic characteristics 
of blood flow need to be examined in detail for exploring the causes and effects of 
flow choking in gravity and microgravity environment for an authentic conclusion 
in the risk assessment of asymptomatic cardiovascular diseases.
Heart failure (HF) is the cardiovascular epidemic of the 21st century [2]. 
Although there has been significant advancement in the diagnosis, prognosis, treat-
ment and prevention of HF with reduced ejection fraction (EF), the morbidity and 
mortality are still extensive. This is particularly true due to the Covid-19 pandemic 
(www.escardio.org). The EF is a blood flow measurement in percentage (%), 
specifying how much blood the left ventricle pumps out with each contraction. The 
EF measurement under 40% may be an indication of HF or cardiomyopathy. An EF 
from 41–49% may be considered as “borderline” cases having the history of stroke 
(memory effect). A normal heart’s EF may be between 50–70%. An EF value higher 
than 75% generally indicates hypertrophic cardiomyopathy (HCM), which could 
affect people of any age [2]. HCM is reported as a cause of acute HF particularly in 
young people, including young athletes. Although all these percentage demarca-
tions of the EF are meaningful for the diagnosis, until the discovery of the Sanal 
flow choking the EF estimations were not supported by any closed-form analytical 
model for taking brilliant clinical decisions case by case. The recent theoretical 
discovery of the Sanal flow choking [1, 2] provides an insight for the risk assess-
ment of asymptomatic cardiovascular diseases. Moreover, the Sanal flow choking 
model could generate universal benchmark data for predicting the condition of 
internal flow choking in CVS for taking an authentic conclusion on the desirable 
EF in terms of blood flow percentage for healthy subjects for reducing the risk of 
acute-heart-failure. The European Society of Cardiology (ESC) reported (2020) 
that patients with cardiovascular risk factors and established cardiovascular disease 
(CVD) represent a vulnerable population when suffering from the Covid-19. It is 
important to note that patients with cardiac injury in the context of Covid-19 have 
an increased risk of morbidity and mortality.
The acute-heart-failure is an event rather than a disease [3, 4]. Therefore, 
many researchers argued for a radical change in thinking and in therapeutic drug 
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development through multidisciplinary research [1–6]. Of late, Kumar et al. [2] 
reported conclusively that the transient event causing the acute-heart-failure is 
due to the phenomenon of internal flow choking (biofluid/Sanal flow choking) at 
a critical total-to-static pressure ratio. Internal flow choking is a compressible fluid 
flow effect caused by the blockage factor, which occurs at a critical blood-pressure-
ratio (BPR), irrespective of the incoming flow velocity. In the CVS, the total pres-
sure is considered as systolic blood pressure (SBP) and the static pressure is denoted 
as diastolic blood pressure (DBP). The physical situation of internal flow choking 
in the micro/nanoscale fluid flows in the circulatory system is more susceptible 
at microgravity condition due to altered variations of blood viscosity, turbulence 
and the BPR (SBP/DBP). During a long-term human spaceflight mission, the 
major factor that affects cardiovascular dysfunctions is the absence of gravity [6]. 
Cardiovascular changes in actual spaceflight differ from those in stimulations such 
as head-down bedrest or dry immersion [7]. The changes in the cardiovascular 
system begin solely with the fluid shift associated with microgravity, followed by 
the decreased circulatory blood volume, cardiac size, and aerobic capacity, and 
the most prominent symptom, postflight orthostatic intolerance. These symptoms 
are generically known as “cardiovascular deconditioning” [7–11]. Microgravity 
environment decreases plasma volume and increases the hematocrit compared with 
the situation on the earth surface, which increases the relative viscosity of blood. 
Since blood viscosity strongly depends on hematocrit there are possibilities of an 
early flow choking in microgravity environment due to an enhanced boundary layer 
blockage [6].
Human blood is a compressible fluid with different degrees of the compressibil-
ity percentage because the specific volume (or density) of blood does change with 
temperature and/or pressure [1, 2]. Therefore, the specific heat at the constant-
pressure (Cp) is always higher than the specific heat at the constant-volume (Cv) of 
all human blood. The ratio of Cp and Cv is defined as the blood-heat-capacity-ratio 
(BHCR), which is an important parameter determining the thermal-tolerance 
level of blood [2]. The specific heat capacity depends on the number of degrees of 
freedom and each independent degree of freedom permits the particles to store 
thermal energy and as a result the BHCR will be always greater than one. It cor-
roborates that blood is a compressible fluid and internal flow choking in CVS could 
occur at a critical BPR irrespective of hypertension or hypotension. Traditionally 
hypertension is considered as a cardiovascular-risk-factor in patients with systemic 
autoimmune and chronic inflammatory diseases. Until the theoretical discovery of 
the internal flow choking in CVS there were no authentic conclusions to support 
whether hypertension or hypotension is more risk with regards to the hemorrhagic 
stroke and acute myocardial infarction [1, 2]. The fact is that an acute-heart-failure 
could occur in both hypertension or hypotension patient because the controlling 
parameter of this event is the blood-pressure-ratio (BPR). In brevity, attaining 
the critical BPR is considered as the risk factor for asymptomatic cardiovascular 
diseases. At the threshold of the internal choking condition, a minor oscillation in 
BPR for both hyper and hypo subjects is likely to aggravate the cardiovascular risk. 
In light of the discovery of internal flow choking in CVS [1, 2], the classic definition 
of the hypertension causing cardiovascular risk is largely arbitrary [SBP ≥140 and/
or DBP ≥90 mmHg]. The prevailing cardiovascular risk data remains challenging 
owing to the fact that the internal flow choking could occur in both hypertension 
or hypotension subjects once SBP/DBP reaches the critical BPR. The internal flow 
choking could happen anywhere in CVS including capillaries, vasa vasorum and/
or nanoscale vessels. Capillaries are tiny blood vessels connecting arteries to veins. 
These blood vessels carry oxygen and nutrients to individual cells throughout the 
body. The vasa vasorum is a network of small blood vessels that are found in large 
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veins (e.g., the venae cavae) and arteries such as the aorta and its branches. These 
small vessels serve to provide blood supply and nourishment for tunica adventitia 
and outer parts of tunica media of large vessels. Arteries deliver blood from the 
heart to the rest of the body and Veins return the blood back to the heart from 
the rest of the body. It is important to note that the pressure inside of arteries 
is very different from the pressure inside of veins. The pressure created by the 
heart pushes the blood through the arteries and the pressure inside the arteries is 
directly related to the blood pressure. The pressure in the veins is very low. Of late 
Kumar et al. [2, 3] reported that not the pressure but the magnitude of the blood-
pressure-ratio (BPR) is the risk factor for acute-heart-failure and the brain hemor-
rhage because at the choked flow condition there are possibilities of the occurrence 
shock wave and pressure-overshoot in any vessel with divergent and/or bifurcation 
region causing aneurysm or wall tearing.
A brain hemorrhage is a type of stroke. It is caused by an artery in the brain 
bursting and causing localized bleeding in the surrounding tissues. Brain arteriove-
nous malformations (AVMs) are abnormal connections of arteries and veins [12]. 
An AVM can develop anywhere in the body, but occurs most often in the brain. 
Brain AVMs are a leading cause of the hemorrhage in children and young adults, 
although they can cause other morbidities such as seizures, focal neurological defi-
cits, and headaches. There is usually high flow through the feeding arteries, nidus, 
and draining veins, which may result in rupture and intracranial hemorrhage, the 
most severe complication of an AVM. Clinically, brain AVMs are technically chal-
lenging and resource-intensive to manage with the available therapeutic modalities 
and often require multi-modal therapy. The factors influencing risk of hemor-
rhage associated with sporadic brain AVM is still poorly understood. It has already 
been established that blood/biofluid is a compressible viscous fluid and internal 
flow choking can occur anywhere in CVS at a critical BPR causing asymptomatic 
hemorrhage. In light of the theoretical discovery of the phenomenon of internal 
flow choking in nano scale fluid flows [1, 2], further studies on the pathogenesis 
of asymptomatic intracranial hemorrhage is envisaged [13]. Briefly, the concept of 
internal flow choking in blood circulatory system provides an insight for the diag-
nosis, prognosis, treatment and prevention of the asymptomatic coronary artery 
disease (CAD) and peripheral artery disease (PAD).
2. Internal flow choking
Internal flow is a flow for which the fluid is bounded by walls. Internal flow 
choking is a compressible fluid flow effect and a fluid dynamic condition in wall-
bounded systems associated with the venturi effect. Admittedly, when a flowing 
fluid at a given pressure and temperature passes through a constriction (such as the 
throat of a convergent-divergent (CD) nozzle or a valve in a pipe) into a lower pres-
sure environment the fluid velocity increases for meeting the continuity condition 
set by the law of nature, viz., the law of conservation of mass. The conservation 
of mass (continuity) is a fundamental concept of physics and it tells us that at the 
steady state condition the mass flow rate through a tube is a constant and equal 
to the product of local density, local velocity, and local cross-sectional area of the 
tube. The local cross-sectional area can alter due to the boundary layer blockage 
(i.e., boundary layer displacement thickness) as a result of the viscous flow effect. 
The cardiovascular system or hemodynamic process is said to be in a steady state 
if the state variables which define the behavior of the system or the process are 
unchanging in time.
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All fluids in nature are viscous and compressible [1] and prone to create bound-
ary layer over the bounding walls altering the effective geometric shape of the 
tube. The magnitude of boundary layer blockage depends up on the rheology of 
fluid and the type of flow featuring from laminar, transitional to turbulent flow 
characteristics. Boundary layer is the layer of fluid in the immediate vicinity of a 
bounding surface where the effects of viscosity are significant in the flow. Note 
that because of the greater velocity gradient at the wall the frictional shear stress 
in a turbulent boundary layer is greater than in a purely laminar boundary layer. 
And as a result, the turbulent boundary layer thickness will be higher than laminar 
boundary layer thickness. The main known parameter characterizing laminar–tur-
bulent transition is the Reynolds number, which is defined as the ratio of inertial 
forces to viscous forces within a fluid which is subjected to the relative internal 
movement due to different fluid velocities. The transition to turbulence can occur 
over a range of Reynolds numbers, depending on many factors, including the wall 
surface roughness, heat transfer, vibration, noise, and other disturbances. The 
parameters influencing the local Reynolds number in a tube are local density, local 
viscosity, local velocity and the local diameter (a characteristic length). In fact, 
a decade before, blood was treated as a Newtonian fluid but later the established 
viscoelastic properties make human blood non- Newtonian [14, 15]. It depends on 
the elastic behavior of red blood cells. For compressible fluids, viscosity depends 
on temperature and varies very slowly with low pressure levels. It is an established 
fact that viscosity variations of fluids will be significant at high pressure levels and 
low temperature. The viscosity of water increases exponentially with decrease in 
temperature and is affected by the type and concentration of solutes. Although 
many empirical laws are available for predicting viscosity of gases, there is no 
established law for predicting the viscosity of blood in all directions as it possesses 
anisotropic characteristics. Anisotropy just refers to the properties of a material 
being directionally dependent. Many biological fluids have elements of anisotropy, 
because they are made of different cells and plasma that react differently to stresses. 
For example, blood has to flow in arteries and veins, which range in size from very 
large to extremely small under pressure pulses emanating from the heart. So the 
corpuscles in the blood vary in shape along the flow direction and in transverse 
directions. When they have to squeeze through a tiny vessel, they are extremely dis-
torted and the “fluid” becomes highly anisotropic. Since Newton’s law of viscosity 
is not a fundamental law of nature; and in light of the theoretical discovery of the 
Sanal flow choking in the CVS, it is desirable to establish a mathematical model to 
predict accurately the directionally dependent viscosity of blood at various patho-
physiological ranges of pressure and temperature for a credible decision making on 
the possibilities of the occurrence of internal flow choking in the circulatory circuit 
a priori. Such a model will be useful for a credible risk assessment of asymptomatic 
cardiovascular diseases through in silico methodology with compressible viscous 
flow models.
The blood/biofluid compressibility effects on mass flow rate have some surpris-
ing results. At a particular total condition, there is a maximum limit of mass flow 
that occurs when the flow Mach number is equal to one (i.e., local flow velocity 
equal to the local velocity of sound). The limiting of the mass flow rate is called 
choking of the flow, which occurs at the sonic fluid flow condition (i.e., Mach 
number (M) equal to one). It is important to note that although the fluid velocity 
reaches sonic condition and becomes choked, the mass flow rate is not choked. The 
mass flow rate can still be increased if the upstream pressure is increased as this 
increases the density of the gas entering the orifice. Internal flow choking occurs 
when sonic velocity is reached at the constriction section. And the flow becomes 
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independent from downstream conditions. In other words, internal flow choking 
occurs in CVS at a critical blood pressure ratio (SBP/DBP), which is governed by the 
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The analytical model (Eq. (1)) derived from the compressible flow theory [1, 5, 
16, 17] dictates the exact condition of internal flow choking in CVS. It is pertinent 
to note that if the blood vessel is having the shape of a convergent-divergent (CD) 
nozzle due to occlusion, stenosis, vasospasm and/or the effect of boundary layer 
blockage (Figure 1) there are possibilities of the generation of shock waves and 
transient pressure-overshoot in the downstream region of the vessel after attaining 
the internal flow choking condition (Eq. (1)) as a result of supersonic flow develop-
ment. Occlusion of the blood vessel causing internal flow choking may be due to 
atherosclerotic plaque, an embolised blood clot, necrosis or a foreign body presence. 
According to the law of nature, with a mathematical proof [5, 16], for a compress-
ible fluid to expand isentropically from subsonic (M < 1) to supersonic (M > 1) 
speeds, it must flow through a convergent-divergent duct or a CD-shaped stream-
tube [5, 6, 16, 17] experiencing with a physical situation of internal flow choking 
at a critical BPR (Figure 2). The critical BPR for internal flow choking is governed 
by the BHCR as dictated by Eq. (1). There are two types of internal flow choking in 
CVS viz., biofluid choking and Sanal flow choking. Biofluid flow choking occurs 
in CVS due to the plaque induced CD nozzle flow effect and/or due to vasospasm 
(Figure 1(a–d)) or any other type of occlusion. A vasospasm is the narrowing of 
the arteries caused by a persistent contraction of the blood vessels, which is known 
as vasoconstriction. Vasospasms can affect any area of the body including the 
brain (cerebral vasospasm) and the coronary artery (coronary artery vasospasm). 
The Sanal flow choking phenomenon is established as the fluid-throat induced 
internal flow choking due to the boundary layer formation in the real world flows 
(continuum/non-continuum) owing to the compressible viscous flow effect [1, 2]. 
The Sanal flow choking creates a physical situation of boundary layer blockage 
persuaded biofluid flow choking of the circulatory circuit at a critical systolic-to-
diastolic blood pressure ratio (BPR) in all the subjects with and without any plaque 
(Figure 1(d–g)) and/or apparent occlusion.
The internal flow choking is a new theoretical concept in biological science 
applicable to continuum and non-continuum biofluid flows. As the pressure of the 
nanoscale biofluid/non-continuum-flows rises, average-mean-free-path diminishes 
and thus, the Knudsen number lowers heading to a zero-slip wall-boundary condi-
tion with compressible viscous flow effect, which increases the risk of cardiovascu-
lar diseases. Eq. (1) tells us that low BPR, high BHCR or high thermal tolerance of 
blood reduces the risk of internal flow choking, which in turn reduces the pos-
sibilities of shock wave generation and pressure overshoot causing asymptomatic 
cardiovascular diseases. At a critical BPR, the Sanal flow choking occurs anywhere 
in the CVS, including micro/nanoscale vessels with sudden expansion/divergence 
or bifurcation regions. The Sanal flow choking leads to supersonic flow develop-
ment heading to the shock wave generation in viscoelastic vessels creating memory 
effect (stroke history). It occurs due to the boundary layer persuaded convergent-
divergent (CD) duct shape of the flow passage (Figure 3).
The shock wave can occur anywhere at any time in the supersonic flow when 
there is a flow compression due to streamtube effect or geometric effect or any 
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other flow disturbance. Normal shock waves create very sharp transient pressure-
overshoot in CVS, which leads to bulging or tearing of vessels. The tearing (hem-
orrhagic stroke) or bulging of vessels (aneurysm) depend on the memory effect 
(stroke history) and relaxation modulus of the viscoelastic vessels. Memory effect 
depends on the strength of the shock wave and the associated occurrence of the 
transient pressure-overshoot over the years due to the frequent fluctuations in BPR, 
due to various reasons, ranging from unchoked to choked biofluid flow conditions. 
Note that large oscillations in BPR leads to arrhythmia. Most heart valve problems 
Figure 1. 
Demonstrations of different physical situations of internal flow choking (biofluid/Sanal flow choking) at a 
critical blood-pressure-ratio (BPR) [1]. (a) physical situation of biofluid choking in an artery with plaque 
deposit similar to a CD nozzle flow passage, (b) demonstrating the possibilities of biofluid choking at a critical 
BPR due to vasospasm, (c) a partially blocked artery demonstrating the CD nozzle flow passage causing 
biofluid choking, (d) demonstrating the possibilities of biofluid choking and Sanal flow choking in an artery 
with plaque and collateral circulation, (e) demonstrating the physical situation of the Sanal flow choking 
at the presence of a stent in an artery with bifurcation, (f) a partially blocked artery with stent creating a 
situation of biofluid flow choking at a critical BPR due to CD nozzle shaped flow passage, (g) demonstrating 
the physical situation of the Sanal flow choking in a healthy subject having an artery with bifurcation.
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involve the aortic and mitral valves, possibly because of its geometric shape similar 
to a convergent-divergent (CD) duct flow passage [2, 6]. All these deliberations lead 
to establish herein that the internal flow choking is an undesirable phenomenon 
in CVS as it leads aneurysm, hemorrhagic stroke, moyamoya disease, myocardial 
infarction. The significant clinical aspect is that; the internal flow choking is 
uniquely regulated by the biofluid/blood heat-capacity-ratio (BHCR). Of late 
V.R.S.Kumar et al. [2] correlate the BHCR with BPR, blood viscosity (BV) and 
ejection fraction (EF) for establishing the concept of internal flow choking causing 
asymptomatic cardiovascular diseases for taking brilliant clinical decisions in case 
by case manner [18–30].
3. Analytical methodology
The analytical prediction of the Sanal flow choking [1, 2] is a breakthrough 
in biological science, which creates a radical change in the diagnostic sciences of 
asymptomatic cardiovascular diseases because the various causes of the Sanal 
flow choking are complementing with all the established concepts in the medical 
sciences [2]. The concepts of Sanal flow choking is reviewed herein for highlighting 
pragmatic solutions for reducing the risk of internal flow choking leading to shock 
wave generation causing asymptomatic cardiovascular diseases. The whole blood 
viscosity is popularly the one of Virchow’s triad, which is a recognized concept pro-
nounces the three wide types of causes that are believed to interpose to thrombosis 
Figure 2. 
Demonstrating the physical situation of the internal flow choking and unchoking condition in a CD duct or a 
CD shaped streamtube.
Figure 3. 
Demonstrating the Sanal flow choking phenomenon in an idealized physical model of an artery with a 
divergent port.
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causing cardiovascular complications, viz., hypercoagulability, hemodynamic 
changes (stasis, turbulence), endothelial injury/dysfunction. Furthermore, it is well 
known that blood is a non Newtonian fluid [2] as blood viscosity changes due to 
fluid force, seasonal effects and blood thinning medications.
Viscosity variations are depending on the shear rate or shear rate history of 
the blood/biofluid, which could vary due to local effects too. Blood temperature 
decreases during the winter season resulting an increase in blood viscosity and the 
inverse effect happens during the summer season [5, 18]. It corroborates that the 
boundary-layer-blockage (BLB) factor causing the Sanal flow choking would alter 
due to the blood viscosity variations as a consequence of the blood-thinning medi-
cation and/or the seasonal effects [2, 18]. Indeed, boundary-layer-blockage induced 
internal flow choking is more prone during the winter season than the summer 
season due to the higher blood viscosity at the relatively low blood temperature. It 
leads to say that the risks of internal flow choking leading to asymptomatic cardio-
vascular diseases would be high during the winter than in the summer season [5, 
18]. It is important to note that disproportionate blood-thinning medication will 
increase the Reynolds number, which produces the high-turbulence-level creating 
enhanced boundary-layer-blockage (BLB)-factor causing an early internal flow 
choking. Therefore, we can establish that relatively high blood viscosity and low 
blood viscosity are risk factors for an early internal flow choking in cardiovascular 
system (CVS) causing asymptomatic stroke/hemorrhage and acute heart failure, 
which is correlating with the established index, viz., International normalized ratio 
(INR). Therefore, the real effect of viscosity on internal flow choking in CVS needs 
to be established through randomized clinical trials for taking preventive strate-
gies for reducing the risk of asymptomatic hemorrhage and acute heart failure. 
On this rationale, it is essential, rather needed, perhaps inevitable to declare an 
exact condition for prohibiting the internal flow choking in the CVS, in terms of 
viscosity, density, Reynolds number, biofluid/blood-heat-capacity-ratio (BHCR), 
blood-pressure-ratio (BPR), the ejection fraction in terms of biofluid/blood flow 
rate (BFR), and stenosis (vessel geometry), which are accomplished through 
the closed-form analytical models (Eqs (2), (3)). Eqs (2), (3) are declaring the 
unchoked flow condition in the CVS, which could predict the cardiovascular risk 
for taking a conclusive clinical decision on each and every subject in all seasons. 
Accurate estimation of the parameters highlighted in Eqs (2), (3) are absolutely 
required for the future health care management of all subjects aiming for prohibit-
ing asymptomatic cardiovascular diseases.
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It is evident from Eq. (1), and Eqs (2), (3) that a decrease in BHCR, DBP and 
the vessel diameter increases the cardiovascular risk, which is correlating with 
the existing clinical findings [2, 18, 28, 29]. Eq. (1) also reveals that an increase in 
systolic blood pressure (SBP) increases the cardiovascular risk (CVR). Briefly, an 
increase in BPR increases the CVR. Eq. (1) and Eqs (2), (3) are two independent 
and complementing conditions set for prohibiting the internal flow choking in 
the CVS. Eq. (2) is an offshoot of Eq. (3), which highlights the coupled effect of 
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thermo-fluid dynamics properties of biofluid/blood along with the vessel block-
age in terms of the hydraulic diameter. Note that nanoscale fluid flow system with 
apparently high-risk blockage (Figure 1(a)) must always maintain the flow Mach 
number less than one as dictated by Eqs (2) and (3) for negating the undesirable 
internal flow choking causing shock wave generation and pressure-overshoot in the 
CVS leading to acute myocardial infarction. In such cases the flow Mach number 
can be retained always less than one by keeping BPR always less than the lower 
critical hemorrhage index (LCHI), which can be achieved by increasing the BHCR 
through drugs or otherwise. Analytical model (Eq. (2)) proves that the stents could 
reduce the risk of the heart attack but no better than drugs for increasing the BHCR 
owing to the fact that the Sanal flow choking could occur with and without stent. 
The impeccable analytical models presented herein as Eqs (2), (3) reveal that the 
usage of blood-thinners without increasing the BHCR create high risk of bleeding 
and stroke. The fact is that the blood-thinner decreases the viscosity and increases 
the Reynolds number, which augments the turbulence level causing an enhanced 
boundary layer blockage, which predisposes for an early flow choking. The flow 
turbulence enhances the deficit of energy in the type of friction, which increases 
the boundary layer blockage in the vessels and generates heat and augment the 
internal energy affecting a reduction in BHCR. Additionally, turbulence enhances 
the perfusion pressure essential to push the blood flow, which creates an early 
undesirable Sanal flow choking in the circulatory system.
3.1 Lower critical hemorrhage index
In order to avoid internal flow choking in CVS an unchoked–fluid-flow condi-
tion must be maintained throughout the circulatory system. It could be achieved 
by maintaining the BPR always lower than the lower-critical-hemorrhage-index 
(LCHI), which is dictated by the lowest value of the BHCR (Eq. (4)) of the evolved 
gases from blood or foreign gases entered in the CVS. Air can enter in veins and 
arteries during surgical procedures. It has been reported that non meticulous brain 
surgeries result in an air embolism. Significant venous air embolism may develop 
acutely during the perioperative period due to a number of causes such as during 
head and neck surgery, spinal surgery, improper central venous and hemodialysis 
catheter handling, etc. The trend of using self-collapsible intravenous (IV) infusion 
bags instead of the conventional glass or plastic bottles has several advantages, one 
of them being protection against air embolism [31].
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Note that BHCR of CO2 is lower than air, which creates an early internal flow 
choking. For instance, if CO2 is the dominant gas in the CVS it is mandatory to 
maintain BPR lower than 1.82, within the pathophysiological range of human 
temperature, for creating an unchoked flow condition for prohibiting the shock 
wave generation [1] causing asymptomatic cardiovascular diseases due to transient 
pressure-overshoot. Note that BHCR of CO2 decreases from 1.31 @ 0 °C to 1.281 
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@ 100 °C. Eq. (4) shows that the BHCR is having the bearing on all the parameters 
highlighted in Eqs (2), (3) for prohibiting the internal flow choking. The fact is that 
at the choked flow condition the critical-BPR is a unique function of BHCR. Briefly, 
the LCHI can be predicted (Eq. (4)) using the lowest value of the BHCR among the 
dominant gases present in the CVS of each subject (human being or animal). 
The upper critical hemorrhage index (UCHI) can be predicted (Eq. (5)) from the 
specific heat of blood at constant pressure (Cp) and the specific heat of blood at 
constant volume (Cv) using the differential scanning calorimeter [6].
4. In vitro methodology
In vitro data [6] shows that nitrogen (N2), oxygen (O2), and carbon dioxide 
(CO2) gases are predominant in fresh blood samples of the human being/Guinea-
pig at a temperature range of 37–40 °C (98.6–104 °F), which increases the risk of 
internal flow choking leading to the asymptomatic cardiovascular risk. It is evident 
from the reported results (Figure 4), exceeding the thermal tolerance level, that 
the possibilities of internal flow choking in the human being is higher than the 
animal (Guinea pig) under the same thermal loading condition as the BHCR of the 
dominant gas evolved in the animal is found consistently higher than the human 
being. As a result, the LCHI is higher for the healthy male Guinea pig as dictated by 
the Eq. (4). The mass spectrum of N2 is reported higher in animal whereas in human 
being CO2 is found higher [1, 6]. The BHCR of N2 is 1.4 and that of CO2 is 1.289 at a 
temperature of 300 K (80.33 F). At this thermal loading condition, an early internal 
flow choking occurs in the human artery at a BPR of 1.82 compared to an animal 
(Guinea pig) artery at a BPR of 1.89. It proves that the thermal tolerance level of the 
healthy Guinea pig is higher and the cardiovascular risk is lower than the human 
being under identical conditions. Therefore, increasing the thermal tolerance level 
in terms of BHCR of the human being is an important factor for reducing the risk of 
asymptomatic cardiovascular diseases caused by the shock waves as a result of inter-
nal flow choking. Figure 5 is demonstrating the percentage variations of evolved 
gases (viz., N2 -m/z = 28, O2 -m/z = 32, CO2 -m/z = 44, Ar -m/z = 40, an unknown 
composite gas -m/z = 28.5), from blood samples of four different healthy human 
beings and one healthy male Guinea pig of four weeks old, during the hyphenated 
technique at a blood temperature of 40 °C (104o F). The estimated UCHI of healthy 
human being of age 23–56 with different blood group is presented in Table 1.
Figure 4. 




5. In silico methodology
Over the decades, bio-medical researchers have been relying on in silico simula-
tion to model and cognize the natural mechanisms behind the creation and evolu-
tion of hemodynamic disorders. It has been recognized that the wall-shear-stress 
exerted on the walls of the blood vessel due to the flow of blood/biofluid is one 
of the main pathogenic factors leading to the occurrence of such disorders. The 
magnitude and distribution of the wall shear stress in a blood vessel can provide an 
insight into the locations of possible aneurysm growth. Furthermore, blockages 
that build up over time can be predicted by having a qualitative understanding of 
the flow profile. In silico methods can be used for modeling and understanding such 
vital internal flows. Obviously, the insights gained from the three-dimensional (3D) 
Batch No. Blood Group SBP/DBP BPR BHCR UCHI @ 37.5o C
3073 O+ 150/90 1.666 3.500 3.110
3074 A+ 120/70 1.714 2.760 2.691
3078 B- 150/90 1.666 2.7292 2.709
3080 O+ 150/90 1.666 2.9935 2.824
3082 A+ 140/96 1.458 2.6759 2.640
Table 1. 
Prediction of the UCHI from the heat capacity ratio of fresh blood samples of healthy human being of  
age 23–56 [2].
Figure 5. 
Demonstrating the percentage variations of evolved gases (viz., N2-m/z = 28, O2 m/z = 32, CO2-m/z = 44, 
Ar-m/z = 40, an unknown composite gas - m/z = 28.5) from the blood samples of four different healthy human 
beings and one Guinea pig during the hyphenated technique at a blood temperature of 40 °C (104o F) [2].
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multi-phase in silico simulation can help design patient-specific treatments and 
forecast asymptomatic cardiovascular risk. In this book chapter, as a proof of the 
concept of fluid-throat persuaded shock waves, we are highlighting the single phase 
in silico results (Figure 6) demonstrating the Sanal flow choking phenomenon 
followed by pressure-overshoot in an idealized physical model of a blood vessel 
with divergent region (see Figure 3) with working fluid as gas. The modeling of 
non-Newtonian behavior of blood flow is an important task in any in silico simula-
tion with fluid-structural interaction for forecasting asymptomatic cardiovascular 
diseases. Additionally, a realistic time-varying boundary condition need to be 
implemented in order to mimic the pulsatile nature of diabatic flow (flow involves 
transfer of heat) of blood in a thermo-viscoelastic vessel.
The in silico result presented in Figure 6 is clearly demonstrating the phenome-
non of the Sanal-flow-choking and the shock-waves generation at the subsonic inflow 
condition (creeping flow) leading to the transient pressure-overshoots (stroke) in 
the downstream region of an artery with divergent port. Figure 6 provides the proof 
of the concept of fluid-throat persuaded flow choking in the CVS. The closed-form 
analytical prediction of the 3D blockage factor [1] at the sonic-fluid-throat location 
is a useful tool for the in vitro and in silico experiments in both the continuum and 
non-continuum flows with due consideration of heat transfer effects (real-world 
fluid flow effect). Note that the phenomenon of Sanal flow choking is a paradigm 
shift in the diagnostic sciences of asymptomatic CVD. Therefore, development of 
a multi-phase, multispecies, viscoelastic fluid-structural interactive in silico model 
capturing the memory effect (stroke history) is a meaningful objective for predicting 
a priori asymptomatic cardiovascular diseases with credibility [2]. Such an effort will 
be helpful for the diagnosis, prognosis, treatment and prevention of the hemorrhagic 
stroke and the acute heart failure of each and every subject with confidence.
Figure 6. 
Single phase in silico result is demonstrating the transient pressure-overshoot (stroke) at 12 milli-second from 
Sanal flow choking time, after reaching the lower critical hemorrhage index (LCHI), in a simulated artery 
with the boundary layer blockage (a case of an internal flow choking and shock wave generation due to gas 
embolism and without any plaque [5]).
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6. Summary and conclusions
Although the diagnostic sciences have been advanced significantly during the 
last eight decades [32–40], until the theoretical discovery of the Sanal flow chok-
ing, the real occurrence of acute-heart-failure was poorly understood, largely 
for the reason that it was an under diagnosis condition [2]. Now the real cause of 
an acute-heart-failure comes to the foreground [1, 2]. All the findings reported 
in this chapter are complementing with the clinical data causing asymptomatic 
cardiovascular diseases. Analytical models, in vitro and in silico results presented 
herein corroborated that a vaccination or a single drug could reduce the risk of 
hemorrhagic stroke and acute heart failure [1, 2]. It could be achieved by increasing 
the BHCR and/or decreasing the BPR. We recognized through this comprehensive 
review that the internal flow choking, leading to the shock-wave generation and the 
transient pressure spike in a blood vessel, is the fundamental cause of asymptomatic 
cardiovascular diseases including hemorrhagic stroke and acute heart failure. Now 
the precipitating factor for the plaque rupture has come to the foreground. We con-
cluded that the boundary-layer-blockage persuaded Sanal flow choking could occur 
anywhere in the circulatory circuit with gas embolism when BPR reaches LCHI. The 
boundary-layer-blockage-factor depends on the BHCR, flow Mach number, biofluid 
viscosity and turbulence, which could alter due to seasonal changes, variations in 
lipoprotein and other contributing factors. The greater the reduction in low-density 
lipoprotein (LDL) cholesterol, the lower the risk of stroke. The shock wave due to 
the Sanal flow choking could disrupt an atherosclerotic plaque or coronary artery 
wall. In a nutshell, the discovery of the biofluid/Sanal flow choking is a paradigm 
shift in the diagnostic sciences of coronary artery disease (CAD) and peripheral 
artery disease (PAD).
In vitro study shows that nitrogen (N2), oxygen (O2), carbon dioxide (CO2), 
and argon (Ar) gases are predominant in fresh blood samples of healthy subjects 
at a temperature range of 37 – 40 °C (98.6 – 104 °F), which enhances the chances 
of internal flow choking (with or without any coronary artery stent) leading to 
pressure-overshoot and acute heart failure. This physical situation is more dan-
gerous in Covid-19 patients, which could lead to cardiac epidemic. We observed 
through in vitro study that (Figure 4), CO2, the gas with the lowest heat capacity 
ratio (HCR), is relatively and consistently higher in the healthy males than the 
healthy male Guinea pig of four weeks old. It reveals that as a preventive measure 
for all subjects with a low BHCR, including patients who are taking blood-thinning 
medication must maintain their BPR always less than 1.82, as dictated by Eq. (4), 
for reducing the risk of asymptomatic CVD.
We concluded that a single anticoagulant drug capable to suppress the tur-
bulence level and enhance the BHCR or a companion medicine along with the 
traditional blood-thinning medications is predestined for meeting the conflicting 
requirements (i.e., decrease viscosity and turbulence simultaneously) of all the 
subjects for reducing the risk of asymptomatic hemorrhage (AH) and acute heart 
failure (AHF). In high risk subjects, (i.e., BPR is very close to the LCHI), a slight 
oscillation in the BPR predisposes to the choking and the unchoking phenomena, 
which could lead to arrhythmia and memory effect. Briefly, this study sheds light 
for exploring new avenues in biological science for discovering new blood-thinning 
drugs for reducing the risk of internal flow choking causing asymptomatic cardio-
vascular diseases [1, 2]. The cardiovascular treatment should be targeted based on 
blood pressure ratio (BPR), instead of blood pressure levels alone, in chronic heart 
failure patients. We concluded that the risk of internal flow choking heading to 
asymptomatic cardiovascular diseases could be decreased by concurrently reducing 
blood viscosity and turbulence by enhancing the BHCR and/or reducing the BPR.
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The discovery of the Sanal flow choking phenomena calls for continuous 
ambulatory blood pressure (BP) and thermal level monitoring in high risk patients 
in the diagnosis and preventive management of asymptomatic cardiovascular 
diseases. The continuous blood pressure and thermal level measurement could be 
done in a more pragmatic way by using a wearable BP monitor with the temperature 
sensor in the modern form of a wristwatch. Analytical methods such as machine 
learning could definitely enhance the accuracy and advance daily wearable device-
based diagnoses [41–49]. Recent studies on heart failure management in gravity and 
microgravity environment (during the long human spaceflight) corroborate that 
the physical situation of the Sanal flow choking phenomena calls for continuous 
ambulatory BP and thermal-level monitoring in astronauts’/cosmonauts [6, 41–50]. 
Note that the Sanal flow choking is more susceptible at microgravity condition 
due to altered variations of blood viscosity, turbulence and the BPR. Microgravity 
environment decreases plasma volume and increases the hematocrit compared with 
the situation on the earth surface, which increases the relative viscosity of blood. 
We concluded that for a healthy-life all subjects (human being/animals) in the 
earth and in the outer space with high BPR necessarily have high BHCR. We also 
concluded that for reducing the cardiovascular risk, all the astronauts/cosmonauts 
should maintain the BPR lower than the lower critical hemorrhage index (LCHI) 
as dictated by the lowest heat capacity ratio (HCR) of the gas generating from the 
biofluid/blood for prohibiting the internal flow choking during the space travel. 
We recommend all astronauts/cosmonauts should wear ambulatory blood pressure 
and thermal level monitoring devices similar to a wristwatch throughout the space 
travel for the diagnosis, prognosis and prevention of internal flow choking leading 
to asymptomatic cardiovascular diseases. The scientific objective of this study and 
review was to discover the correlation between the thermal tolerance level in terms 
of BHCR, the BPR, blood viscosity, ejection fraction (EF) and the cardiovascular 
risk leading to AH and AHF, which we could achieve herein. We concluded that 
designing the precise blood thinning regimen is vital for attaining the desired 
therapeutic efficacy and negating undesirable flow choking leading to acute-heart 
failure. For a healthy-life all subjects with high-BPR inevitably have high-BHCR 
for reducing the risk of the internal flow choking (biofluid/Sanal flow choking) 
triggering the AHF due to the shock wave generation. We corroborated that, the 
acute-heart-failure (AHF) is a transient episode and not an illness. In a nutshell, a 
single drug capable to increase BHCR and/or decrease the BPR could reduce the risk 
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